$GILD Recent Headlines Gilead's high pricing o
Post# of 94265
Posted On: 07/13/2014 10:02:11 AM
$GILD Recent Headlines
Gilead's high pricing of Sovaldi draws inquiry from Senate committee 1:36 p.m. July 11, 2014 - blogs.marketwatch.com
Bull rolls on, but opportunities start to dwindle 1:52 p.m. July 10, 2014 - The Trading Deck
S&P 500, Nasdaq retest major support 12:12 p.m. July 8, 2014 - Michael Ashbaugh
S&P 500, Nasdaq retest major support 11:57 a.m. July 8, 2014 - Michael Ashbaugh
Growth stocks are doing most bullish thing they can 3:23 p.m. July 1, 2014 - The Trading Deck
Robo-advisors, Syrian strikes and the stock-market shift they signal 6:45 a.m. June 25, 2014 - blogs.marketwatch.com
Health-care inflation heating back up 10:24 a.m. June 24, 2014 - blogs.marketwatch.com
Medtronic’s real problem is innovation, not taxation 6:45 a.m. June 19, 2014 - Tim Mullaney
Rival to Gilead's pricey Sovaldi expected to hit market later this year 7:28 a.m. June 18, 2014 - blogs.marketwatch.com
Tyson falls on Hillshire deal; Apple gains post-split 3:49 p.m. June 9, 2014 - Saumya Vaishampayan
Lobbyists for insurers, big pharma trade barbs over high drug costs 3:10 p.m. June 2, 2014 - blogs.marketwatch.com
Industry titan UnitedHealth misses boom in sector 10:53 a.m. May 29, 2014 - Russ Britt
Gilead says its drug gives hepatitis C patients more cost-effective cure 5:06 p.m. April 30, 2014 - blogs.marketwatch.com
Why a diverse ETF portfolio is right for these times 6:29 a.m. April 30, 2014 - John Prestbo
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
What Obamacare problems? Aetna results not showing any ill effects 12:34 p.m. April 24, 2014 - blogs.marketwatch.com
U.S. stocks tumble; S&P 500 ends 6-day run 4:46 p.m. April 23, 2014 - Anora Mahmudova
Apple, Facebook stuck in red ahead of earnings 3:02 p.m. April 23, 2014 - Saumya Vaishampayan
U.S. stock futures pause after six-session win streak 8:57 a.m. April 23, 2014 - Sara Sjolin
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Biogen's Profit Rolls Amid Recent Drug Launches 6:14 p.m. July 11, 2014 - Investors Business Daily
Senators Investigating Hepatitis C Drug Pricing 5:45 p.m. July 11, 2014 - The Wall Street Journal Interactive Edition
Senators Ask Gilead To Explain Sovaldi Pricing 10:35 a.m. July 11, 2014 - Investors Business Daily
Senators ask Gilead for Sovaldi pricing info 10:09 a.m. July 11, 2014 - Seeking Alpha
Trade-Ideas: Gilead (GILD) Is Today's New Lifetime High Stock 9:46 a.m. July 11, 2014 - TheStreet.com
Stocks Hitting 52-Week Highs 9:13 a.m. July 11, 2014 - benzinga.com
7 Most Heavily Shorted Nasdaq Stocks 8:43 a.m. July 11, 2014 - 247WallSt.com
J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views 3:31 p.m. July 10, 2014 - benzinga.com
My High Share Buyback And Dividend Growth Portfolio 2nd Quarter 2014 Update 12:05 p.m. July 10, 2014 - Seeking Alpha
14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014 11:54 a.m. July 10, 2014 - TheStreet.com
Gilead Sciences Can Hit Par By The End Of The Year 11:35 a.m. July 10, 2014 - Seeking Alpha
A Pre-Earnings Update On Gilead 10:59 a.m. July 10, 2014 - Seeking Alpha
Gilead Sciences: Cause For Concern? 10:25 a.m. July 10, 2014 - Seeking Alpha
Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14) 6:27 a.m. July 10, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: WMB AA BIIB REGN CELG GILD UNUM 6:00 a.m. July 10, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Hunting for Bargains 7:53 p.m. July 9, 2014 - TheStreet.com
3 Drugs Stocks Driving The Industry Higher 1:03 p.m. July 9, 2014 - TheStreet.com
Grading Sobek's Mid-Year Biotech Stock Predictions 10:14 a.m. July 9, 2014 - TheStreet.com
Stock Market News for July 09, 2014 - Market News 10:06 a.m. July 9, 2014 - Zacks.com
Hottest Healthcare Stocks Now – SGEN GILD TEVA IRWD 8:30 a.m. July 9, 2014 - InvestorPlace.com
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus 6:30 a.m. July 1, 2014 - PR Newswire - PRF
AIDSVu Releases New Maps that Depict Impact of HIV in American Cities 9:50 a.m. June 27, 2014 - BusinessWire - BZX
Top White House AIDS Official Visits San Francisco Clinic on National HIV Testing Day 9:00 a.m. June 27, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to Japan’s Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C 3:01 a.m. June 27, 2014 - BusinessWire - BZX
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the Wells Fargo Healthcare Conference on Tuesday, June 17 5:00 p.m. June 16, 2014 - BusinessWire - BZX
Gilead Announces Phase 3 Data Showing That the Fixed-Dose Combination of Ledipasvir/Sofosbuvir Achieved 100 Percent Sustained Virologic Response (SVR12) Among Patients with Chronic Hepatitis C in Japan 8:00 p.m. June 15, 2014 - BusinessWire - BZX
Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors 3:30 p.m. June 13, 2014 - PR Newswire - PRF
Critical Alerts For Ralph Lauren, Rackspace Hosting, Gilead Sciences, Fortinet, and Express Scripts Technology Released By InvestorsObserver 9:31 a.m. June 13, 2014 - PR Newswire - PRF
Prescription for Profit: Pharma-Biotech Industry Continues Mega-Billion Dollar Merger & Acquisition Binge, an Industrial Info News Alert 6:15 a.m. June 11, 2014 - Marketwire
Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, June 10 5:00 p.m. June 9, 2014 - BusinessWire - BZX
Gilead Announces Updated Phase 2 Results for Investigational GS-9973 in Relapsed Chronic Lymphocytic Leukemia 8:30 a.m. June 3, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene 5:10 a.m. May 28, 2014 - PR Newswire - PRF
AHF: ‘Negligent Corporate Welfare’ Pushes Gilead to Top of S&P 500 5:40 p.m. May 22, 2014 - BusinessWire - BZX
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape 12:38 p.m. May 22, 2014 - PR Newswire - PRF
Gilead’s Investigational GS-5806 Reduces Viral Load and Clinical Symptoms in Phase 2 Respiratory Syncytial Virus (RSV) Challenge Study in Adults 5:00 p.m. May 20, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 2014 UBS Healthcare Conference on Tuesday, May 20 5:00 p.m. May 19, 2014 - BusinessWire - BZX
Gilead's high pricing of Sovaldi draws inquiry from Senate committee 1:36 p.m. July 11, 2014 - blogs.marketwatch.com
Bull rolls on, but opportunities start to dwindle 1:52 p.m. July 10, 2014 - The Trading Deck
S&P 500, Nasdaq retest major support 12:12 p.m. July 8, 2014 - Michael Ashbaugh
S&P 500, Nasdaq retest major support 11:57 a.m. July 8, 2014 - Michael Ashbaugh
Growth stocks are doing most bullish thing they can 3:23 p.m. July 1, 2014 - The Trading Deck
Robo-advisors, Syrian strikes and the stock-market shift they signal 6:45 a.m. June 25, 2014 - blogs.marketwatch.com
Health-care inflation heating back up 10:24 a.m. June 24, 2014 - blogs.marketwatch.com
Medtronic’s real problem is innovation, not taxation 6:45 a.m. June 19, 2014 - Tim Mullaney
Rival to Gilead's pricey Sovaldi expected to hit market later this year 7:28 a.m. June 18, 2014 - blogs.marketwatch.com
Tyson falls on Hillshire deal; Apple gains post-split 3:49 p.m. June 9, 2014 - Saumya Vaishampayan
Lobbyists for insurers, big pharma trade barbs over high drug costs 3:10 p.m. June 2, 2014 - blogs.marketwatch.com
Industry titan UnitedHealth misses boom in sector 10:53 a.m. May 29, 2014 - Russ Britt
Gilead says its drug gives hepatitis C patients more cost-effective cure 5:06 p.m. April 30, 2014 - blogs.marketwatch.com
Why a diverse ETF portfolio is right for these times 6:29 a.m. April 30, 2014 - John Prestbo
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
What Obamacare problems? Aetna results not showing any ill effects 12:34 p.m. April 24, 2014 - blogs.marketwatch.com
U.S. stocks tumble; S&P 500 ends 6-day run 4:46 p.m. April 23, 2014 - Anora Mahmudova
Apple, Facebook stuck in red ahead of earnings 3:02 p.m. April 23, 2014 - Saumya Vaishampayan
U.S. stock futures pause after six-session win streak 8:57 a.m. April 23, 2014 - Sara Sjolin
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Biogen's Profit Rolls Amid Recent Drug Launches 6:14 p.m. July 11, 2014 - Investors Business Daily
Senators Investigating Hepatitis C Drug Pricing 5:45 p.m. July 11, 2014 - The Wall Street Journal Interactive Edition
Senators Ask Gilead To Explain Sovaldi Pricing 10:35 a.m. July 11, 2014 - Investors Business Daily
Senators ask Gilead for Sovaldi pricing info 10:09 a.m. July 11, 2014 - Seeking Alpha
Trade-Ideas: Gilead (GILD) Is Today's New Lifetime High Stock 9:46 a.m. July 11, 2014 - TheStreet.com
Stocks Hitting 52-Week Highs 9:13 a.m. July 11, 2014 - benzinga.com
7 Most Heavily Shorted Nasdaq Stocks 8:43 a.m. July 11, 2014 - 247WallSt.com
J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views 3:31 p.m. July 10, 2014 - benzinga.com
My High Share Buyback And Dividend Growth Portfolio 2nd Quarter 2014 Update 12:05 p.m. July 10, 2014 - Seeking Alpha
14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014 11:54 a.m. July 10, 2014 - TheStreet.com
Gilead Sciences Can Hit Par By The End Of The Year 11:35 a.m. July 10, 2014 - Seeking Alpha
A Pre-Earnings Update On Gilead 10:59 a.m. July 10, 2014 - Seeking Alpha
Gilead Sciences: Cause For Concern? 10:25 a.m. July 10, 2014 - Seeking Alpha
Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14) 6:27 a.m. July 10, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: WMB AA BIIB REGN CELG GILD UNUM 6:00 a.m. July 10, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Hunting for Bargains 7:53 p.m. July 9, 2014 - TheStreet.com
3 Drugs Stocks Driving The Industry Higher 1:03 p.m. July 9, 2014 - TheStreet.com
Grading Sobek's Mid-Year Biotech Stock Predictions 10:14 a.m. July 9, 2014 - TheStreet.com
Stock Market News for July 09, 2014 - Market News 10:06 a.m. July 9, 2014 - Zacks.com
Hottest Healthcare Stocks Now – SGEN GILD TEVA IRWD 8:30 a.m. July 9, 2014 - InvestorPlace.com
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus 6:30 a.m. July 1, 2014 - PR Newswire - PRF
AIDSVu Releases New Maps that Depict Impact of HIV in American Cities 9:50 a.m. June 27, 2014 - BusinessWire - BZX
Top White House AIDS Official Visits San Francisco Clinic on National HIV Testing Day 9:00 a.m. June 27, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to Japan’s Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C 3:01 a.m. June 27, 2014 - BusinessWire - BZX
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the Wells Fargo Healthcare Conference on Tuesday, June 17 5:00 p.m. June 16, 2014 - BusinessWire - BZX
Gilead Announces Phase 3 Data Showing That the Fixed-Dose Combination of Ledipasvir/Sofosbuvir Achieved 100 Percent Sustained Virologic Response (SVR12) Among Patients with Chronic Hepatitis C in Japan 8:00 p.m. June 15, 2014 - BusinessWire - BZX
Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors 3:30 p.m. June 13, 2014 - PR Newswire - PRF
Critical Alerts For Ralph Lauren, Rackspace Hosting, Gilead Sciences, Fortinet, and Express Scripts Technology Released By InvestorsObserver 9:31 a.m. June 13, 2014 - PR Newswire - PRF
Prescription for Profit: Pharma-Biotech Industry Continues Mega-Billion Dollar Merger & Acquisition Binge, an Industrial Info News Alert 6:15 a.m. June 11, 2014 - Marketwire
Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, June 10 5:00 p.m. June 9, 2014 - BusinessWire - BZX
Gilead Announces Updated Phase 2 Results for Investigational GS-9973 in Relapsed Chronic Lymphocytic Leukemia 8:30 a.m. June 3, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene 5:10 a.m. May 28, 2014 - PR Newswire - PRF
AHF: ‘Negligent Corporate Welfare’ Pushes Gilead to Top of S&P 500 5:40 p.m. May 22, 2014 - BusinessWire - BZX
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape 12:38 p.m. May 22, 2014 - PR Newswire - PRF
Gilead’s Investigational GS-5806 Reduces Viral Load and Clinical Symptoms in Phase 2 Respiratory Syncytial Virus (RSV) Challenge Study in Adults 5:00 p.m. May 20, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 2014 UBS Healthcare Conference on Tuesday, May 20 5:00 p.m. May 19, 2014 - BusinessWire - BZX
(0)
(0)